Onconetix, Inc. Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
Onconetix, Inc. (ONCO) had Stock Repurchase Program Number Of Shares Authorized To Be Repurchased of 125.00 thousand shares as of 2022-11-10, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2026-08-13
- 2022-11-10: Stock Repurchase Program Number Of Shares Authorized To Be Repurchased 125.00K shares.
| Period end | Stock Repurchase Program Number Of Shares Authorized To Be Repurchased |
|---|---|
| 2022-11-10 | 125.00K shares 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |